New York State Common Retirement Fund

New York State Common Retirement Fund (NYSCRF) is a public pension fund headquartered in Albany, New York, with an additional office in New York City. Established in 1921, it provides retirement, disability, and death benefits primarily to police and firefighter personnel, as well as other eligible participants. The organization manages pension funds and principal investment funds, engaging in various investment strategies that include alternative investments, public equity, and debt markets both domestically and internationally. NYSCRF's investment approach encompasses buyouts, distressed debt, international private equity, real estate, and venture capital, often committing significant capital to limited partnerships. With a mission to secure the financial well-being of its beneficiaries, NYSCRF plays a crucial role in the retirement landscape of New York State.

Evril Clayton Jr.

Deputy Director of Global Equity

6 past transactions

Israel Bonds

Debt Financing in 2023
Israel Bonds is an investment corporation that trades in bonds issued by the government of Israel for international investors.

Donahue Schriber

Venture Round in 2017
Donahue Schriber is a company that specializes in developing unique shopping destinations that cater to the needs of the community. They focus on creating a mix of tenants that complement the lifestyle of consumers and reflect the character of the neighborhood. Their approach involves customized solutions that emphasize the synergy between the tenant mix and the local community, resulting in shopping centers that become integral parts of their respective communities.

OyaGen

Grant in 2013
OyaGen, Inc. is a biotechnology company based in Rochester, New York, established in 2003. The company specializes in the discovery, development, and commercialization of pharmaceutical therapies that leverage RNA and DNA editing enzymes. Its innovative platform technology focuses on editing enzymes that can influence a variety of biological functions, including antiviral responses, cancer treatment, immunoglobulin gene rearrangements, inflammation, ion channel activity, LDL reduction, neuro-cognitive functions, and the expression of red blood cells in the fetal liver. By chemically altering RNA or DNA molecules, OyaGen aims to provide enhanced therapeutic options for conditions such as human immunodeficiency virus and other diseases.

SchoolNet

Series D in 2009
Schoolnet is a provider of instructional improvement software designed to enhance student achievement and teacher quality while improving operational efficiency for K-12 school districts. The company offers a data-driven instructional management suite that includes web-based products and solutions, enabling educators to access essential data, reports, tools, and content. This suite supports the assessment of student and school performance, with a focus on districts in major cities such as Atlanta, Chicago, Philadelphia, and Washington, D.C.

Peridrome Corporation

Series A in 2008
Peridrome offers software services, strategic and tactical analysis, and technical expertise to wealth management organizations.

IPLogic

Venture Round in 2005
IPLogic, Inc. is a growing firm specializing in voice and data solutions aimed at helping organizations achieve their business objectives. The company offers a range of services including unified communications, network security, mobility and wireless applications, managed services, multimedia solutions, data storage and protection, and IT staffing. Operating primarily in New York, Vermont, Massachusetts, Pennsylvania, Ohio, and West Virginia, IPLogic focuses on understanding each client's unique culture and industry needs. By evaluating, selecting, and deploying tailored technology solutions, the firm aims to ensure stability and continuity for its clients while facilitating smooth transitions to next-generation technologies. Through its commitment to creating effective technology strategies, IPLogic enables corporations to optimize operations and maintain productivity over time.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.